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Abstract
The United States continues to spend an unprecedented
amount of annual money on healthcare. However, the
costs of providing care may not appropriately reflect the
quality of care patients are receiving. This is particularly
concerning when examining the projected increase in
total joint arthroplasty (TJA) procedures over the next
few decades, which are expected to increase to nearly 4
million procedures annually. The Center for Medicare and
Medicaid Services (CMS) has responded by increasingly
shifting reimbursements from the less efficient fee-forservice repayment model to value-based repayment.
The Comprehensive Care for Joint Replacement (CJR)
bundle payment model has recently been implemented
as part of this shift towards value-based care delivery.
The CJR repayment model, developed based on the
success of the elective Bundled Payments for Care
Improvement (BPCI) initiative, is an episodic bundled
payment for TJA procedures, putting more financial
responsibility on hospitals with the aim of improving
quality of care, reducing costs, and decreasing local and
regional cost and quality variability amongst providers
and hospitals. I reviewed current studies on the BPCI and
CJR model, including benefits associated with reducing
patient readmissions to the hospital; limited costs and
postoperative complications associated with post-acute
care facilities and patient length of stay; and instituting
evidence-based protocols for preoperative, perioperative,
and postoperative care. Promising data exists that suggests
these programs may help incentivize reducing costs
and improving the quality of care provided to patients
undergoing TJA procedures.

Introduction
Healthcare spending in the United States (US) has risen
to unprecedented levels. The US designates roughly $3.2
trillion annually to healthcare, which accounts for 17.8% of
the gross domestic product and equates to approximately
$9990 per person.1 Furthermore, costs of Medicare and
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Medicaid constitute about $1.2 trillion (37%) of total
healthcare spending in the US.1 Although we spend a
notable amount of money, the quality of care delivered has
not kept pace. According to Davis et al,2 the US ranks last
amongst 11 industrialized countries in overall healthcare
quality, efficiency, and equity in 2014. The soaring costs
yet middling quality of the US healthcare system suggest
a pressing value issue. Subsequently, there has been an
appeal to transition away from the traditional fee-forservice repayment model to help improve efficiency in
healthcare services through a more value and quality-based
repayment model
In particular, hip and knee arthroplasty make up a large
portion of the Center for Medicare & Medicaid Services
(CMS) spending. In 2014, Medicare spending on total joint
arthroplasty (TJA) hospitalizations alone was $7 billion
for 400,000 procedures,3 which accounted for 5.7% of all
yearly Medicare expenditures.4 By 2030, the number of
total knee arthroplasty (TKA) and total hip arthroplasty
(THA) procedures, respectively, in the US annually are
projected to increase to approximately 3,500,000 (673%
increase) and more than 500,000 (174% increase).5 As a
payer for many of these procedures, CMS will experience
a considerable cost burden. Additionally, costs associated
with TJA vary substantially between geographical and local
markets.3,6 These increasing volumes and varying prices
have resulted in the development and implementation of
an alternative value-based repayment model from CMS,
called the Comprehensive Care for Joint Replacement
(CJR) model, which took effect in April 2016.7,8
The CJR model aims to hold hospitals accountable for
the quality and cost of care while incentivizing improved
coordination among providers involved in hip and knee
replacement surgery.3 The CJR is modeled on the success
of the voluntary Bundled Payments for Care Improvement
(BPCI). The general payment model is best described
as an episodic bundled payment for a TJA procedure3
where payers reimburse a contracted price for various
services within a specific episode of care.7 In the CJR
model, this episode is defined as the index admission and
90-day postoperative period. In the CJR, each involved
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care provider bills Medicare for appropriately provided
services during the episode of care. CMS then reconciles
all qualifying payments and compares the total costs to
the target (or contracted) price. Should the hospital spend
less than the target price, the difference is provided to the
hospital as a payment. Hospitals and providers can share
in that payment. As the model becomes more established,
any excessive costs by hospitals above the target price
will be penalized the difference. Nearly all medical and
rehabilitation care in that 90-day period are included in
the total costs, with few exceptions.8 The target price in
the first year is based on historical costs for the hospital;
however, during the initial 5-year period, this transitions to
a regional-based target price (Figure 1).
As a whole, using the CJR model may push hospitals
and providers to identify and eliminate inefficiencies in
caring for TJA patients, which can reduce affiliated costs
and improve care quality. Because of the rapid transition
in target pricing, hospitals will need to act swiftly to
remain financially solvent. Experience with the BPCI has
allowed the orthopaedic community to objectively identify
cost-saving and quality-improving opportunities for TJA
procedures in preparation for CJR.

Figure 1. Comprehensive Care for Joint Replacement (known as CJR)
target price calculation. Multiple price modifiers such as Medicare
savings discounts and capped losses are not represented here. Further
information on targeting pricing can be found at https://innovation.cms.
gov/initiaties/cjr.

Reducing Readmissions
Readmission during an episode of care can be extremely
costly to a hospital system in a bundled payment model.
Although not all readmissions can be eliminated, reducing
the complications that lead to readmissions can decrease
costs and improve patient-care quality. Clair et al9 found
that overall 90-day readmission rates for primary TJA
procedures were 10%. Surgical complications added costs

of $36,038 for THA readmissions and $38,953 for TKA
readmissions, whereas medical complications added costs
of $22,775 for THA readmissions and $24,183 for TKA
readmissions. Bosco et al10 quantified the cost burden
of unplanned readmissions during the first 30 days after
TJA and TJA in the Medicare population. Cost burden
represents the necessary profit margin of each procedure in
order to account for readmissions and remain financially
solvent. Unplanned readmissions during this time for THA
and TKA were both 2.4%, with a cost burden of 4.3% and
2.8%, respectively. Unplanned readmissions after revision
THA and revision TKA were significantly more common
and costly, with readmission rates of 9.5% and 11.9% and
cost burdens of 8.3% and 11.9%, respectively.
In an effort to identify patients at risk for readmission,
Kurtz et al11,12 reviewed Medicare claims data on more
than 950,000 TKA and 440,000 THA procedures. These
studies found that readmission rates for THA and TKA
during the 90-day postoperative period were 10.5% and
8.6%, respectively. Patients requiring a perioperative blood
transfusion were at increased risk of readmission, whereas
patients discharged to home or had hospital stays less than
5 days had significantly decreased risk of readmission. As
surgeon procedural volume increased, patient risk for
readmission was decreased.
Boraiah et al13 developed a readmission risk assessment
tool (RRAT) and analyzed the relationship between
cumulative RRAT scores and readmission risk. This tool
assessed numerous modifiable and non-modifiable risk
factors including tobacco use, Staphylococcus Aureus
colonization, obesity, cardiovascular disease, history or
risk factors for venous thromboembolism, neurocognitive
or psychological problems, physical conditioning, and
diabetes. Of the modifiable risk factors assessed with
this tool, diabetes, history of venous thromboembolic
disease, and smoking were significantly associated with
readmission regardless of patient age. Using this tool,
patients with a cumulative RRAT score of 3 or greater were
significantly associated with higher odds of readmission.
Importantly, infection continues to be a leading cause
for readmission.9,11-13 This tool may help guide surgeons
towards modifying certain risk factors to reduce the
patient’s odds of sustaining a complication or readmission
before they undergo elective TJA.
Hospital readmissions are costly for hospitals and can
be morbid for patients. Identifying high-risk patients,
managing modifiable risk factors preoperatively, and
focusing on high-quality perioperative care may
significantly reduce the risk of readmission, improving
overall patient health and quality of care while reducing
hospital costs.
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Post-Acute Care Facility Discharges and
Length of Stay
The 90-day period after discharge can be a considerable
source of cost in a bundle-payment model, starting with
the early post-discharge period. Patient discharge to a postacute care (PAC) facility, such as a skilled nursing facility
or inpatient rehabilitation facility, can lead to a significant
increase in cost in a bundle-payment model. Patients
discharged to PAC facilities instead of home can incur
30% to 40% higher costs during an episode of care.14,15
In 2015, a total of $10.8 billion was spent on discharges
to PAC facilities after TJA.15 PAC spending is the single
largest contributor to variation in Medicare spending in the
US, accounting for 73% of regional-spending variations.16
Reducing patient discharges to PAC facilities is clearly an
opportunity at cost reduction.
Multiple strategies have been proposed to reduce PAC
discharges after TJA. Snow et al16 evaluated the impact of
a “prehabilitation” program on use of PAC services after
TJA. Patients who underwent preoperative physical therapy
had an overall 29% reduced usage of PAC services at an
average adjusted cost reduction of $1215, predominantly
through reduced skilled nursing facility and home health
agency payments. The average cost of preoperative
physical therapy was $100, limited to one or two sessions.
The author suggested that the value of this therapy was
predominantly in the patient’s planning for recovery
and training in assistive walking devices as opposed to
intensive range of motion and strength regimens. In
another study, Slover et al17 used decision analysis to assess
the impact of extending inpatient hospital stays to avoid
PAC facility discharge in a 90-day episode of care. Results
showed that an inpatient stay can be extended to a total of
8.2 days after surgery if a patient is discharged to home and
remain more cost-effective than discharge to a PAC facility.
The authors suggested that savings that could be realized
with such a strategy are primarily the result of relatively low
costs of additional days in the acute care facility, compared
to a more expensive stay at a PAC facility.
However, length of stay has been identified as a
significant risk factor for readmission.11,12,18 Williams et
al18 found that length of stay greater than 4 days after TJA
is a significant risk factor for readmission within 90 days
after surgery. Patients with higher American Society of
Anesthesiologists (ASA) physical-status scores who had a
length of stay greater than 4 days had higher readmission
risk during the 31- to 90-day postoperative period than
those with lower ASA scores. Longer hospital admissions
increase the risk of complications such as hospital-acquired
infections and venous thromboembolism.18 Interestingly,
the study also identified discharge to a facility other than

9

home as an independent risk factor for readmission. The
risk of readmission for patients who required prolonged
hospital stays is significant and can remain so even through
the later period of the episode of care.
Although discharging to home may be more costeffective than a PAC-facility discharge, it does not come
without risk. Yao et al15 assessed numerous risk factors
for severe adverse events or readmission for patients
discharged to home after TJA. Patients who experienced
severe complications or readmission were older, smoked,
obese, or functionally dependent, and the odds of a
severe adverse event or readmission increased with
each additional risk factor. About 70% of unplanned
readmissions occurred within the first 2 weeks after
discharge. The author concluded that patients discharged
to home should be risk-stratified, and home healthcare
surveillance should be more aggressively used in high-risk
patients during the early post-discharge period to reduce
complications and readmissions.
Ultimately, there is a balance between discharge location,
length of stay, and patient risk factors that optimizes
cost and improves the quality of care. The optimal postdischarge pathway for each patient will require accurate
risk stratification and subsequent allocation of resources.
Further investigation needs to be performed to identify
these risk factors and determine effective ways to modify
care accordingly.

Standardized Care Pathways
Developing an efficient, streamlined care pathway for TJA
patients has been proposed as an opportunity to improve
value in an episodic bundle payment model by using
cost-reduction techniques and providing improved quality
of perioperative care. As a method to reduce inefficiency
or use of duplicative services, hospitals have adopted
standardized care pathways for TJA practices. These
pathways create customary, evidence-based protocols
for patient care in the preoperative, perioperative, and
postoperative periods.19
Froemke et al7 evaluated the impact of implementing a
standardized care pathway, with a bundled payment and
gainshare model, on patient care and costs. The study
found several areas of improvement after implementation
of this pilot initiative. Compared to the pre-pilot cohort,
the pilot cohort had significantly reduced length of stay,
greater discharge to home with self-care, decreased in
discharge to skilled nursing facilities and home with
healthcare, and a reduction of total-allowed claims by
6% per case. Concomitantly, quality measures including
Surgical Care Improvement Project compliance, Press
Ganey hospital scores, and 3-month postoperative Western
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Ontario and McMaster Universities Arthritis Index scores
were favorable compared to national benchmarks. Tessier
et al19 assessed cost differences and readmission rates of
more than 77,000 Medicare TJA patients from 68 different
orthopaedic groups within the US with and without
defined clinical-care pathways. The study noted that these
cohorts had similar readmission rates; however, groups
with a defined clinical-care pathway averaged $3189 less
costs for THA and $2466 less cost per case compared to
those without defined clinical-care pathways.
Standardized care pathways for TJA patients have the
potential to reduce inefficiency by streamlining common
services, create clearly defined roles for each care provider,
and align the interests of all providers with the patient to
assure an excellent, cost-effective outcome.

Conclusion
TJA is a major contributor to increasing costs seen by CMS,
and this will only continue to grow. Procedural volume
is increasing rapidly, and costs have been highly variable.
With the implantation of the CJR model, there is increased
incentive for providers to improve efficiency, decrease costs,
and improve the quality of patient care. However, because
of increasing influence of regional prices in the early stages
of implementation and annually adjusted target prices,
the available opportunities to reduce inefficiencies in care
delivery and improve patient outcomes must be clearly
delineated to help providers adjust to a rapidly changing
landscape and remain solvent. Reducing hospital length
of stay, decreasing use of PAC facilities and resources,
reducing hospital readmissions, and implementing
standardized care pathways have all been shown to have a
positive impact on cost reduction and patient care quality.
Avenues need to be explored that help improve the
overall patient-care experience by reducing complications
and enhancing objective patient-outcome measures in
order to continue to improve the overall value of total joint
replacement surgery. It is essential that all the stakeholders
in a patient’s episode of care are incentivized to develop
methods to improve patient outcomes within their
scope of practice. Gainsharing is a financial relationship
between a hospital and care providers involved in a TJA
episode of care where costs savings realized as a payment
to the hospital can be shared with these providers. The
CJR model allows gainsharing opportunities, which may
provide incentives for improved care coordination and
quality. Strategies to reduce potentially unnecessary
readmissions can decrease costs, but more importantly
reduce unnecessary burden on TJA patients and their
families. Some potential strategies that may reduce these
readmission events include developing defined emergency

room care pathways for TJA patients, post-discharge
patient monitoring by clinical staff, and preoperative
planning sessions with individual patients where
procedures are established for patients to navigate potential
complications.
As spending decreases with downward pressure on
payments and increasing risk being absorbed by hospitals,
a possible consequence may be the withholding of a
potentially beneficial TJA procedure from patients with
increased risks. As the current CJR model does not account
for preoperative medical care in their target price, there
is significant opportunity to improve and even eliminate
patient risk factors before surgery, such as poor glycemic
control, smoking, or obesity, while keeping costs controlled.
However, a major concern with this model will be the
financial impact it will have on institutions currently
providing TJA procedures to higher risk patients and
whether or not this will lead to decrease in access to care
for this population. We must critically assess the impact of
this program and others like it to assure that patients are
receiving the care they require.
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